SPC Logo

Micolette Micro-enema

Last Updated on eMC 15-Apr-2011 View changes  | Pinewood Healthcare Contact details

1. Name of the medicinal product

Micolette Micro-enema

2. Qualitative and quantitative composition

Sodium lauryl sulphoacetate

45 mg )

Sodium citrate BP

450 mg ) per 5 ml

Glycerol BP

625 mg )

3. Pharmaceutical form

Micro-enema

4. Clinical particulars
4.1 Therapeutic indications

Micolette is indicated whenever an enema is necessary for chronic and acute constipation in the rectum and sigmoid colon. Also indicated for use in constipation in geriatrics, pediatrics and obstetrics.

4.2 Posology and method of administration

Route of administration: Rectal

Adults and children aged 3 years and over:

Lubricate the nozzle with one drop of the contents; insert full length of nozzle into the rectum and squeeze tube until total contents have been administered. Two tubes may be necessary in severe cases. When used in children the nozzle should be inserted to half its length only.

Children under 3 years: Not recommended.

Elderly: There are no special requirements for elderly patients but as with all medicines the lowest effective dose should be used.

4.3 Contraindications

Inflammatory or ulcerative bowel disease. Acute gastrointestinal conditions.

4.4 Special warnings and precautions for use

Excessive use of Micolette micro-enema may cause diarrhoea and fluid loss. In such cases, Micolette should be discontinued and appropriate therapy instituted.

4.5 Interaction with other medicinal products and other forms of interaction

Prolonged use may interfere with the absorption of some vitamins.

4.6 Fertility, pregnancy and lactation

Indicated for use in constipation in obstetrics.

4.7 Effects on ability to drive and use machines

Not applicable.

4.8 Undesirable effects

Very occasionally, a slight cramp may occur. Prolonged use may lead to irritation of the anal canal.

4.9 Overdose

Not applicable.

5. Pharmacological properties
5.1 Pharmacodynamic properties

Sodium citrate is a 'peptizing' agent which liberates water present in the faeces. Sorbitol enhances this action. Sodium lauryl sulphoacetate is a wetting agent. Glycerol promotes peristalsis and evacuation of the lower bowel.

5.2 Pharmacokinetic properties

Not applicable.

5.3 Preclinical safety data

Not applicable.

6. Pharmaceutical particulars
6.1 List of excipients

Sorbitol solution BP

3.12 g

Potassium sorbate BP

6.2 mg

Water

6.25 g

6.2 Incompatibilities

None known

6.3 Shelf life

60 months (unopened).

6.4 Special precautions for storage

Store below 25°C

6.5 Nature and contents of container

Disposable low density polyethylene tube with nozzle and removable cap.

(Pack of 12 x 5 ml tubes).

6.6 Special precautions for disposal and other handling

Not applicable.

7. Marketing authorisation holder

Pinewood Laboratories Limited

Ballymacarbry,

Clonmel,

Co. Tipperary

Ireland.

8. Marketing authorisation number(s)

PL 04917/0064

9. Date of first authorisation/renewal of the authorisation

15 August 2003/ 09 March 2009

10. Date of revision of the text

09/03/2009

Company contact details

Pinewood Healthcare

Company image
Address

Ballymacarby, Clonmel, Co. Tipperary, Co. Tipperary, Ireland

Fax

+ 353 52 6136311

Medical Information e-mail
Telephone

+353 52 6186000

Medical Information Direct Line

+44 1978 661 261

Medical Information Fax

+44 1978 661 702

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

glycerol, sodium citrate, sodium lauryl sulphoacetate

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue